Purification and some properties of kappa toxin of Clostridium perfringens.
D000818:Animals; D000992:Antitoxins; D002499:Centrifugation, Density Gradient; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D003016:Clostridium perfringens; D003238:Connective Tissue / Q000187:drug effects; D003851:Deoxyribonucleases / Q000032:analysis; D006168:Guinea Pigs; D006470:Hemorrhage / Q000139:chemically induced; D006821:Hyaluronoglucosaminidase / Q000032:analysis; D006863:Hydrogen-Ion Concentration; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D051379:Mice; D008970:Molecular Weight; D009132:Muscles / Q000187:drug effects; D009439:Neuraminidase / Q000032:analysis; D010447:Peptide Hydrolases / Q000032:analysis; D011506:Proteins / Q000032:analysis; D011817:Rabbits; D051381:Rats; D014118:Toxins, Biological / Q000032:analysis / Q000302:isolation & purification* / Q000494:pharmacology
D000992:Antitoxins; D011506:Proteins; D014118:Toxins, Biological; D003851:Deoxyribonucleases; D009439:Neuraminidase; D006821:Hyaluronoglucosaminidase; D010447:Peptide Hydrolases